COMPUGROUP MEDICAL - BUY | EUR66 No outstanding growth, but limited risk
COMPUGROUP MEDICAL - BUY | EUR66No outstanding growth, but limited risk
Unsurprisingly, medium-term targets are confirmed
Stable and secular growth drivers, unlikely to be hit by a recession
Significant adj. EBITDA margin levers
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.